BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Biota, Inc. 

2232 Rutherford Road

Carlsbad  California  92008  U.S.A.
Phone: 760-804-6980 Fax: 760-804-2740


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Start Up





 Company News
Biota, Inc. Receives $4.2 Million R&D Tax Credit 11/7/2012 8:46:38 AM
Biota, Inc., Nabi Biopharmaceuticals (NABI) Amend Merger Terms; $54 Million Transaction Down to $27 Million 9/18/2012 6:59:03 AM
Biota, Inc. Announces Inavir Achieves Primary Endpoint in Phase III Prevention Study 8/22/2012 9:12:57 AM
Biota, Inc. Announces Royalties from Inavir(R) and Relenza(TM) for Q4 and F2011 8/1/2011 8:38:28 AM
Biota, Inc. Announces Preliminary Phase III Prophylaxis Trial Results for CS-8959 6/27/2011 10:00:19 AM
Biota, Inc. Obtains US$2.9M National Institutes of Health (NIH) Grant for the Development of Novel Antibacterial 6/10/2011 8:52:50 AM
Biota, Inc. Announces Relenza Royalty for March 2011 Quarter 4/28/2011 8:56:11 AM
Biota, Inc. Announces Relenza Royalty for March 2011 Quarter 4/28/2011 8:29:56 AM
Biota, Inc. Announces Relenza September Quarter Royalty of $2.1 Million from GlaxoSmithKline (GSK) 10/22/2010 11:41:53 AM
Biota, Inc.'s HCV Research Agreement With Boehringer Ingelheim Corporation Concludes 4/20/2010 3:31:01 PM
123